|
ISRCTN
|
ISRCTN05282752
|
|
ClinicalTrials.gov identifier
|
|
|
Public title
|
Effect of valdecoxib pretreatment on pain and secondary hyperalgesia associated with the heat/capsaicin model in healthy volunteers
|
|
Scientific title
|
|
|
Acronym
|
N/A
|
|
Serial number at source
|
N/A
|
|
Study hypothesis
|
Selective COX-2 inhibitors significantly attenuate central sensitization and decrease secondary hyperalgesia
|
|
Lay summary
|
Not provided at time of registration
|
|
Ethics approval
|
IRB approval at Penn State Hershey Medical Center
|
|
Study design
|
Prospective, double blind, randomized, cross-over
|
|
Countries of recruitment
|
United States of America
|
|
Disease/condition/study domain
|
None (healthy volunteers)
|
|
Participants - inclusion criteria
|
Healthy volunteers, both genders
|
|
Participants - exclusion criteria
|
Pregnancy, known allergy to COX-2 inhibitors, current infection or treatment with analgesics
|
|
Anticipated start date
|
01/01/2004
|
|
Anticipated end date
|
01/01/2006
|
|
Status of trial
|
Completed |
|
Patient information material
|
|
|
Target number of participants
|
40
|
|
Interventions
|
Administration of single dose 40 mg valdecoxib or placebo orally (PO).
Measurement of heat/cold pain threshold and area of heat/capsaicin-induced hyperalgesia.
|
|
Primary outcome measure(s)
|
Area of secondary hyperalgesia
|
|
Secondary outcome measure(s)
|
Pain threshold for cold/heat pain
|
|
Sources of funding
|
Independent Investigator Grant from Pfizer Inc.
|
|
Trial website
|
|
|
Publications
|
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16529650&query_hl=1&itool=pubmed_DocSum
|
|
Contact name
|
Dr
Piotr
Janicki
|
|
Address
|
Dept. Anesthesiology
Penn State Hershey Medical Ctr
H187
500 University Drive
|
|
City/town
|
Hershey
|
|
Zip/Postcode
|
PA 17036
|
|
Country
|
United States of America
|
|
Email
|
pjanicki@psu.edu
|
|
Sponsor
|
Pfizer Inc. (USA)
|
|
Address
|
235 E. 42nd Str
|
|
City/town
|
New York
|
|
Zip/Postcode
|
NY, 10017-5755
|
|
Country
|
United States of America
|
|
Email
|
maria.mccauley@pfizer.com
|
|
Date applied
|
29/11/2005
|
|
Last edited
|
16/08/2011
|
|
Date ISRCTN assigned
|
30/11/2005
|